UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

c‐Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2011-09, Vol.54 (3), p.879-889

2011

Volltextzugriff (PDF)

Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor‐β

Hepatology (Baltimore, Md.), 2010-05, Vol.51 (5), p.1635-1644

2010

Volltextzugriff (PDF)

Stem cells in liver diseases and cancer: Recent advances on the path to new therapies

Hepatology (Baltimore, Md.), 2012-01, Vol.55 (1), p.298-306

2012

Volltextzugriff (PDF)

Epithelial‐to‐mesenchymal transition of murine liver tumor cells promotes invasion

Hepatology (Baltimore, Md.), 2010-09, Vol.52 (3), p.945-953

2010

Volltextzugriff (PDF)

Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics

BMC cancer, 2011-09, Vol.11 (1), p.396-396, Article 396

2011

Volltextzugriff (PDF)

Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A–deficient mice

Hepatology (Baltimore, Md.), 2008-04, Vol.47 (4), p.1288-1297

2008

Volltextzugriff (PDF)

The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma

PloS one, 2015-05, Vol.10 (5), p.e0128159-e0128159

2015

Volltextzugriff (PDF)

Expansion of CD133‐Expressing Liver Cancer Stem Cells in Liver‐Specific Phosphatase and Tensin Homolog Deleted on Chromosome 10‐Deleted Mice

Stem cells (Dayton, Ohio), 2009-02, Vol.27 (2), p.290-299

2009

Volltextzugriff (PDF)

Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via β‐catenin activation

Hepatology (Baltimore, Md.), 2007-10, Vol.46 (4), p.1187-1197

2007

Volltextzugriff (PDF)

Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model

Hepatology (Baltimore, Md.), 2012-01, Vol.55 (1), p.141-152

2012

Volltextzugriff (PDF)

CD133+ liver cancer stem cells from methionine adenosyl transferase 1A–deficient mice demonstrate resistance to transforming growth factor (TGF)‐β–induced apoptosis

Hepatology (Baltimore, Md.), 2009-04, Vol.49 (4), p.1277-1286

2009

Volltextzugriff (PDF)

Expansion of Hepatic Tumor Progenitor Cells in Pten -Null Mice Requires Liver Injury and Is Reversed by Loss of AKT2

Gastroenterology (New York, N.Y. 1943), 2010-12, Vol.139 (6), p.2170-2182

2010

Volltextzugriff (PDF)

Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells

PloS one, 2012-11, Vol.7 (11), p.e50401-e50401

2012

Volltextzugriff (PDF)

A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer

Pharmaceuticals (Basel, Switzerland), 2016-03, Vol.9 (2), p.18

2016

Volltextzugriff (PDF)

Isolation of CD133+ liver stem cells for clonal expansion

Journal of visualized experiments, 2011-10 (56)

2011

Volltextzugriff (PDF)

Bone marrow fails to differentiate into liver epithelium during murine development and regeneration

Hepatology (Baltimore, Md.), 2007-05, Vol.45 (5), p.1250-1260

2007

Volltextzugriff (PDF)

Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model

Journal of hepatology, 2017-01, Vol.66 (1), p.75-85

2017

Volltextzugriff (PDF)

A CD133‐Expressing Murine Liver Oval Cell Population with Bilineage Potential

Stem cells (Dayton, Ohio), 2007-10, Vol.25 (10), p.2419-2429

2007

Volltextzugriff (PDF)

Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization

Proteome science, 2010-11, Vol.8 (1), p.61-61

2010

Volltextzugriff (PDF)

Stem cells in drug discovery, regenerative medicine and cancer

Genome medicine, 2011-03, Vol.3 (3), p.15-15

Rountree, C Bart

2011

Volltextzugriff (PDF)

104 The Reversal of Epithelial-to-Mesenchymal Transition by Delivery of MicroRNA 200 Inhibits Liver Cancer Cell Migration and Invasion

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-19-S-19

2010

Volltextzugriff (PDF)

Abstract C5: Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (23_Supplement), p.C5-C5

2009

Volltextzugriff (PDF)

The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met.sup.+ Hepatocellular Carcinoma

PloS one, 2015-05, Vol.10 (5)

2015

Volltextzugriff (PDF)

Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-[beta]

Hepatology (Baltimore, Md.), 2010-05, Vol.51 (5), p.1635

2010

Volltextzugriff (PDF)

Successful Chemoimmunotherapy against Hepatocellular Cancer in a Novel Murine Mode

Journal of hepatology, 2016-08, Vol.66 (1), p.75-85

2016

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

c‐Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma

Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor‐β

Stem cells in liver diseases and cancer: Recent advances on the path to new therapies

Epithelial‐to‐mesenchymal transition of murine liver tumor cells promotes invasion

Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics

Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A–deficient mice

The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma

Expansion of CD133‐Expressing Liver Cancer Stem Cells in Liver‐Specific Phosphatase and Tensin Homolog Deleted on Chromosome 10‐Deleted Mice

Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via β‐catenin activation

Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model

CD133+ liver cancer stem cells from methionine adenosyl transferase 1A–deficient mice demonstrate resistance to transforming growth factor (TGF)‐β–induced apoptosis

Expansion of Hepatic Tumor Progenitor Cells in Pten -Null Mice Requires Liver Injury and Is Reversed by Loss of AKT2

Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells

A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer

Isolation of CD133+ liver stem cells for clonal expansion

Bone marrow fails to differentiate into liver epithelium during murine development and regeneration

Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model

A CD133‐Expressing Murine Liver Oval Cell Population with Bilineage Potential

Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization

Stem cells in drug discovery, regenerative medicine and cancer

104 The Reversal of Epithelial-to-Mesenchymal Transition by Delivery of MicroRNA 200 Inhibits Liver Cancer Cell Migration and Invasion

Abstract C5: Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β

The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met.sup.+ Hepatocellular Carcinoma

Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-[beta]

Successful Chemoimmunotherapy against Hepatocellular Cancer in a Novel Murine Mode

Suchergebnisse filtern